Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s MUsT Draft Guidance Extends Challenge To Wider OTC Drug Industry

May 23 2018

• By Ryan Nelson

female scientist working with microscope

Related Content

OTC Monograph Legislation Clears Another Hurdle Despite Exclusivity Concerns

May 11 2018

FDA’s ‘Exploratory’ MUsT Won't Affect OTC Sunscreen Rulemaking Schedule

Mar 29 2018

FDA To Try Its Hand At Sunscreen Absorption Study, A MUsT For TEA Sponsors

Mar 16 2018

More GRASE Time For 6 OTC Antiseptic Ingredients But 24 Flushed In Final Rule

Feb 16 2018

FDA's Sunscreen Data Guidance Lacks Risk/Benefit Balance – Stakeholders

Feb 25 2016

Additional Topics

Regulation FDA Cosmetics Consumer

More from Archive

More from HBW Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.